Red
Brand Name(s):
Indication:Ovarian Cancer
Rationale:1,2,3,8
Considered:Jan-11
Review Date:Jan-26
Comments:
NICE TA389
Paclitaxel in combination with platinum or as monotherapy is recommended within its marketing authorisation as an option for treating recurrent ovarian cancer